Skip to content

Short Message System (SMS) Monitoring Intended for the Suicidal Patients

Short Message System (SMS) Monitoring Intended for the Suicidal Patients: Study of Efficiency

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02106949
Enrollment
530
Registered
2014-04-08
Start date
2014-08-20
Completion date
2019-03-22
Last updated
2025-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Having Realized a Suicide Attempt

Keywords

suicide attempt, SMS monitoring, recurrence, phone, prevention control, tertiary healthcare

Brief summary

The study wants to prove that SMS monitoring reduced the number of suicide attempts in six months according to the beginning of its implementation in the group of the patients benefiting SMS compared with the group of patients benefiting from the usual care.

Interventions

DEVICESMS contact with patient after discharge in intervention group

Sponsors

Technopôle Brest-Iroise: LANESTEL SARL, 38 rue Jim Sevellec, 29200 Brest
CollaboratorUNKNOWN
University Hospital, Brest
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Written informed consent * Surviving a suicide attempt * Leaving directly the emergency department or hospitalized less than 7 days * Being able to be joined by telephone mobile

Exclusion criteria

* under guardianship * Patient who are not able to provide a consent

Design outcomes

Primary

MeasureTime frame
Number of suicide reattempts in every group6 months

Secondary

MeasureTime frame
Number of suicide reattempts in every group13 months
Total number of suicidal second recurrences in every group6 months
Number of deaths by suicide6 months and 13 months
Score in the scale C-SSRSinclusion, 6 months and 13 months
Presence of a disorder in the MINI: characterization of the comorbidity6 months and 13 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026